Skip to main content

Day: March 23, 2021

Hexagon Purus AS: Annual Report 2020

The Board of Directors of Hexagon Purus AS approved the company’s Annual Report 2020 on 22 March 2021. Please find the Annual Report 2020 attached. The report is also available on www.hexagonpurus.com. Contacts: Salman Alam, Vice President Corporate Development, Hexagon PurusTelephone: +476 12 713 | salman.alam@hexagonpurus.com Dilip Warrier, CFO, Hexagon PurusTelephone: +1 949-236-5528 | dilip.warrier@hexagonpurus.com About Hexagon Purus AS Hexagon Purus, a Hexagon Composites company, is a world leading provider of hydrogen type 4 high-pressure cylinders, battery packs and vehicle systems integration for fuel cell electric and battery electric vehicles. Hexagon Purus enables zero emission solutions for light, medium and heavy-duty vehicles, buses, ground storage, distribution, maritime, rail and aerospace. Learn more at www.hexagonpurus.com...

Continue reading

TRACON Pharmaceuticals Announces Poster Presentation at the 2021 AACR Virtual Annual Meeting

SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that a poster highlighting the pivotal Phase 2 ENVASARC clinical trial will be presented at the upcoming American Association for Cancer Research (AACR) virtual meeting, being held April 10-15, 2021. The poster will include an oral review by Sandra D’Angelo, M.D., from Memorial Sloan Kettering Cancer Center.Poster Title:    ENVASARC: A Pivotal Trial of Envafolimab, and Envafolimab in Combination with Ipilimumab, in Patients with Advanced...

Continue reading

Denbury Names Brad Whitmarsh Executive Director, Investor Relations

PLANO, Texas, March 23, 2021 (GLOBE NEWSWIRE) — Denbury Inc. (NYSE: DEN) (“Denbury” or the “Company”) today announced that Brad Whitmarsh has joined Denbury as Executive Director, Investor Relations. Mr. Whitmarsh has worked in the oil and gas industry for over 20 years and brings significant investor relations experience to Denbury. Most recently, Mr. Whitmarsh served as Vice President, Investor Relations for Noble Energy, Inc., from 2013 until its acquisition by Chevron Corporation in 2020. Prior to Noble Energy, Mr. Whitmarsh was Vice President of Investor Relations at Kosmos Energy immediately following its initial public offering. Mr. Whitmarsh holds a Bachelor of Business Administration degree in Accounting from Texas A&M University. “We are thrilled to welcome Brad to Denbury,” said Mark Allen, Denbury’s Executive...

Continue reading

Todos Medical Enters Into Automation and Reagent Supply Agreement with MAJL Diagnostics

NEW YORK, NY, REHOVAT, ISRAEL, and ATLANTA, GA, March 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening, diagnosis and immune support, as well as developing blood tests for early detection of cancer and Alzheimer’s disease, today announced that it has entered into an automation and reagent supply agreement with MAJL Diagnostics (“MAJL”).  Under the terms of the agreement, Todos will implement its automation solution, including Tecan™ liquid handlers, automated RNA extraction machines, as well as a 384-well PCR machine capable of conducting COVID, cancer genetics and pharmacogenomics testing, in order to become the provider of all COVID-19 PCR testing reagents and supplies. Upon completion of the...

Continue reading

Full House Resorts Names New Cripple Creek, Colorado Resort; Announces Mississippi Tidelands Lease Option Agreement

LAS VEGAS, March 23, 2021 (GLOBE NEWSWIRE) — Full House Resorts, Inc. (NASDAQ: FLL) today announced the name and branding of its luxury hotel and casino project in Cripple Creek, Colorado: Chamonix Casino Hotel. Located adjacent to the Company’s existing Bronco Billy’s Casino, Chamonix will bring a new level of elegance and comfort to the heart of the historic mining district. Chamonix will feature approximately 300 four-star guest rooms and VIP suites—the first luxury guest rooms in the market—as well as a spacious, new, elegant and exciting casino gaming area. Chamonix’s new fine dining experience is being designed to attract culinary travelers from throughout Colorado, including nearby Colorado Springs, Pueblo and Cañon City, as well as the Denver Metropolitan Area. Chamonix will also feature extensive meeting and convention...

Continue reading

Daré Bioscience to Host Full Year 2020 Financial Results and Company Update Conference Call and Webcast on March 30, 2021

SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Tuesday, March 30, 2021, to review its financial results for the year ended December 31, 2020 and to provide a Company update. To access the conference call via phone, dial (844) 831-3031 (U.S.) or (443) 637-1284 (international). The conference ID number for the call is 6441759. The live webcast can be accessed under “Presentations, Events & Webcasts” in the Investors section of the Company’s website at http://ir.darebioscience.com. Please log in approximately 5-10 minutes prior to the call to register and to download and install any necessary software. To access the replay, please call (855) 859-2056...

Continue reading

Digital Ally, Inc. Sets Date to Announce Fourth Quarter 2020 and Year-End Operating Results

 Digital Ally to Discuss Year-End Earnings Call Wednesday, March 31, 2021 at 11:15 a.m. Eastern Time Lenexa, KS, March 23, 2021 (GLOBE NEWSWIRE) — Digital Ally, Inc. (NASDAQ: DGLY) which develops, manufactures, and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety and event security, today announced that it will host an investor conference call on Wednesday, March 31, 2021 at 11:15 a.m. Eastern time to discuss its operating results for the fourth quarter and year ended December 31, 2020, its ShieldTM Health Protection Product line and other topics of interest. The Company will release its operating results for the fiscal 2020 year in a press release prior to the investor conference call on March 31, 2021. Shareholders and other interested parties...

Continue reading

PLATFORM(WD) Advances Choom’s Digital Strategy with New Website

VANCOUVER, British Columbia., March 23, 2021 (GLOBE NEWSWIRE) — Choom Holdings Inc. (“Choom” or the “Company”) (CSE: CHOO; OTCQB: CHOOF), a fast-expanding Canadian retail cannabis company is pleased to announce it has launched its new proprietary ecommerce platform, powered by PLATFORMWD. The value of Choom’s newly acquired digital team and assets have come to fruition with the release of the Choom 2.0 site. The elevated retail experience customers have come to expect in-store has now come to life online, supporting one of the brands key strategic pillars of a strong omni-channel ecosystem. Some of the key attributes of the fully customized site include full mobile optimization, increased speed, best-in-class SEO, SMS notifications, in-store fulfilment, including delivery and pickup options. “We’re betting big on digital and the...

Continue reading

Vincerx Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

License agreement with Bayer AG secures oncology portfolio including clinical-stage PTEFb/CDK9 inhibitor with encouraging Phase 1 activity Successful completion of business combination transaction, raising approximately $62 million Strengthened leadership with appointments of Chief Medical Officer, Chief Scientific Officer, and General Counsel and Chief Legal Officer Phase 1b studies in in Myc-driven hematologic malignancies and solid tumors, as well as relapsed/refractory Chronic Lymphocytic Leukemia to initiate in 1H 2021 PALO ALTO, Calif., March 23, 2021 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported financial results for the fourth quarter and full year, ended December...

Continue reading

Arizona Gold Reports Progress Towards Gold Production

TORONTO, March 23, 2021 (GLOBE NEWSWIRE) — Arizona Gold Corp. (TSX: AZG, OTCQB: AGAUF) (“Arizona Gold” or the “Company”) is very pleased to provide a project update at its 100% owned Copperstone gold mine located in Arizona, United States. Project Funding As previously announced on November 23, 2020 the Company closed a US$18 million project financing with Star Royalties Ltd. for the restart of operations at the Copperstone gold mine. The US$18 million advance payment under the Streaming Agreement will be provided in three equal installments, with the first two US$6 million installments having been received. The remaining US$6 million installment will be advanced at the request of Arizona Gold, as it incurs expenditures for the restart of Copperstone gold mine. Initial installments, totaling US$12 million, are being allocated to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.